Drug repurposing strategy part 1: from approved drugs to agri-bactericides leads
Authors:
- 14 October 2022
- journal article
- research article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 76 (1) , 27-51
Abstract
Phytopathogenic bacteria are a major cause of crop mortality and yield reduction, especially in field cultivation. The lack of effective chemistry agri-bactericides is responsible for challenging field prevention and treatment, prompting the development of long-lasting solutions to prevent, reduce, or manage some of the most devastating plant diseases facing modern agriculture today and in the future. Therefore, there is an urgent need to find lead drugs preventing and treating phytopathogenic bacterial infection. Drug repurposing, a strategy used to identify novel uses for existing approved drugs outside of their original indication, takes less time and investment than Traditional R&D Strategies in the process of drug development. Based on this method, we conduct a screen of 700 chemically diverse and potentially safe drugs against Xanthomonas oryzae PV. oryzae ACCC 11602 (Xoo), Xanthomonas axonopodis PV. citri (Xac), and Pectobacterium atrosepticum ACCC 19901 (Pa). Furthermore, the structure-activity relationship and structural similarity analysis of active drugs classify potent agri-bactericides into 8 lead series: salicylanilides, cationic nitrogen-containing drugs, azole antifungals, N-containing group, hydroxyquinolines, piperazine, kinase inhibitor and miscellaneous groups. MIC values were evaluated as antibacterial activities in this study. Identifying highly active lead compounds from the screening of approved drugs and comparison with the currently applied plant pathogenic bactericide to validate the bactericidal activity of the best candidates and assess if selected molecules or scaffolds lead to develop new antibacterial agents in the future. In conclusion, this study provides a possibility for the development of potent and highly selective agri-bactericides leads.Keywords
This publication has 47 references indexed in Scilit:
- Antimicrobial resistance (AMR) and plant-derived antimicrobials (PDAms) as an alternative drug line to control infections3 Biotech, 2013
- Current Challenges and Trends in the Discovery of AgrochemicalsScience, 2013
- Use of Natural Products as Chemical Library for Drug Discovery and Network PharmacologyPLOS ONE, 2013
- Top 10 plant pathogenic bacteria in molecular plant pathologyMolecular Plant Pathology, 2012
- Exploiting drug-disease relationships for computational drug repositioningBriefings in Bioinformatics, 2011
- Lessons from 60 years of pharmaceutical innovationNature Reviews Drug Discovery, 2009
- Transcriptional analysis of the sweet orange interaction with the citrus canker pathogens Xanthomonas axonopodis pv. citri and Xanthomonas axonopodis pv. aurantifoliiMolecular Plant Pathology, 2008
- Modes of Action of the New Arylguanidine Abafungin beyond Interference with Ergosterol Biosynthesis and in vitro Activity against Medically Important FungiChemotherapy, 2008
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- Safeguarding production—losses in major crops and the role of crop protectionCrop Protection, 2004